Cargando…
Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
Low-molecular-weight heparins are approved for primary and secondary venous thromboembolism prevention. Tinzaparin is the low-molecular-weight heparin with the highest average molecular weight. The purpose of this systematic review is to provide an update regarding the safety profile of tinzaparin,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818003/ https://www.ncbi.nlm.nih.gov/pubmed/33464938 http://dx.doi.org/10.1177/1076029620979592 |